아마린 코퍼레이션(AMRN)는 NASDAQ에 상장된 Healthcare · Drug Manufacturers - General 기업입니다. 현재가 $13.68 (-1.37%), 시가총액 $0.29B, 52주 최저~최고 $10.98 ~ $20.25.
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in
아마린 코퍼레이션의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
아마린 코퍼레이션의 현재 주가는 $13.68 (-1.37%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
아마린 코퍼레이션의 시가총액은 약 $0.29B입니다.
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and intern